Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.

In unadjusted Cox models, for resistant variants detected at 20% ( Table 3 ), there was an association between presence of both NRTI/NNRTI PDR with longer time to VS, but this did not reach statistical significance (HR, 0.42; 95% CI, 0.16–1.12).

also in 111,027 other papers